Business Context and Reporting Period
Company: EyePoint Pharmaceuticals, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: January 4, 2019
Event: Announcement of the 2019 Annual Meeting of Stockholders.
Financial Metrics
This filing does not contain financial data. Revenue, profit, cash flow, margins, debt, and liquidity metrics are not reported in this document.
Material Changes
The primary material change reported is the advancement of the 2019 Annual Meeting of Stockholders date by more than 30 days from the anniversary of the previous meeting.
- New Meeting Date: Tuesday, June 25, 2019.
- Record Date: April 26, 2019 (Stockholders of record as of this date are entitled to vote).
- Location: 480 Pleasant Street, Watertown, Massachusetts 02472.
- Time: 9:00 a.m. local time.
Guidance, Outlook, and Corporate Governance
Due to the change in the meeting date, new deadlines for stockholder proposals have been established:
- Proposal Deadline: March 27, 2019.
- Requirements: Written notice must be received by the Corporate Secretary at the executive offices by the close of business on the deadline date.
- Scope: Applies to proposals for inclusion in proxy materials under Rule 14a-8 and nominations for director election under the Company's bylaws.
The filing contains no management commentary on business outlook, risks, contingencies, or unusual items.
Key Facts for Investor Verification
- Verify the new Annual Meeting date of June 25, 2019, and the record date of April 26, 2019.
- Note the March 27, 2019 deadline for submitting stockholder proposals or director nominations.
- Confirm the meeting location at the Company's Corporate Headquarters in Watertown, MA.